Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Advances in Diagnosis and Management of Cutaneous Adverse Drug Reactions [[electronic resource] ] : Current and Future Trends / / edited by Neil H. Shear, Roni P. Dodiuk-Gad
| Advances in Diagnosis and Management of Cutaneous Adverse Drug Reactions [[electronic resource] ] : Current and Future Trends / / edited by Neil H. Shear, Roni P. Dodiuk-Gad |
| Edizione | [1st ed. 2019.] |
| Pubbl/distr/stampa | Singapore : , : Springer Singapore : , : Imprint : Adis, , 2019 |
| Descrizione fisica | 1 online resource (XII, 314 p. 95 illus., 91 illus. in color.) |
| Disciplina | 353.998 |
| Soggetto topico |
Pharmacy
Pharmacology Drug Safety and Pharmacovigilance Pharmacology/Toxicology |
| ISBN | 981-13-1489-6 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Section I. Introduction -- 1. Introduction: Classification, Terminology, Epidemiology and Etiology of Cutaneous Adverse Drug Reactions -- Section II. Pathomechanisms of Cutaneous Adverse Drug Reactions -- 2. Immunology of Cutaneous Adverse Drug Reactions -- 3. Pharmacogenomics and Cutaneous Adverse Drug Reactions -- 4 Viral Reactivation in Cutaneous Adverse Drug Reactions -- 5. Using Technology to Learn About Immunology of Cutaneous Adverse Drug Reactions -- Section III. Clinical Perspectives of Cutaneous Adverse Drug Reactions -- 6. Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (Epithelial Necrolysis) -- 7. Drug Reaction with Eosinophilia and Systemic Symptoms -- 8. Acute Generalized Exanthematous Pustulosis -- 9. Urticarial Reactions to Drugs -- 10. Dermatological Adverse Events from Cancer Treatments -- 11. Cutaneous Adverse Drug Reactions in Pediatric Population -- 12. Cutaneous Drug Reactions in the Elderly -- 13. Cutaneous Adverse Drug Reactions in Human Immunodeficiency Virus Patients -- 14. Cutaneous Adverse Drug Reactions from Anti-Tuberculosis Treatment -- Section IV. Approach to the Patient with a Cutaneous Adverse Drug Reaction -- 15. Practical Approach to Diagnosis and Management of Cutaneous Adverse Drug Reactions -- 16. Histopathology of Severe Drug Eruptions -- 17. Evaluation of Drug Safety Literature: A Guide for the Practicing Dermatologist -- 18. In vitro and in vivo tests in Cutaneous Adverse Drug Reactions -- 19. Pharmacovigilance of Cutaneous Adverse Drug Reactions -- Section V. Epilogue -- 20. Future Directions and Unmet Research Needs in Cutaneous Adverse Drug Reactions -- 21. Atlas of Cutaneous Adverse Drug Reactions. |
| Record Nr. | UNINA-9910350239403321 |
| Singapore : , : Springer Singapore : , : Imprint : Adis, , 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Antibiotic Resistance in the Environment [[electronic resource] ] : A Worldwide Overview / / edited by Célia M. Manaia, Erica Donner, Ivone Vaz-Moreira, Peiying Hong
| Antibiotic Resistance in the Environment [[electronic resource] ] : A Worldwide Overview / / edited by Célia M. Manaia, Erica Donner, Ivone Vaz-Moreira, Peiying Hong |
| Edizione | [1st ed. 2020.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 |
| Descrizione fisica | 1 online resource (XII, 344 p. 1 illus.) |
| Disciplina | 616.9041 |
| Collana | The Handbook of Environmental Chemistry |
| Soggetto topico |
Environmental chemistry
Pharmacology Microbiology Pharmacovigilance Medical microbiology Environmental Chemistry Drug Safety and Pharmacovigilance Medical Microbiology Resistència als medicaments Efecte dels medicaments sobre els microorganismes Química ambiental |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-030-55065-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Antibiotic resistance in the environment: expert perspectives -- Antibiotic resistant bacteria in wildlife -- Genomic surveillance for One Health antimicrobial resistance: understanding human, animal, and environmental reservoirs and transmission -- Antibiotic resistance in pharmaceutical industry effluents and effluent-impacted environments -- Antibiotic resistance in municipal wastewater: A special focus on hospital effluents -- Control strategies to combat dissemination of antibiotic resistance in urban water systems -- Antibiotic resistance, sanitation and public health -- Antibiotic resistance and sanitation in India: current situation and future perspectives -- Mitigating antimicrobial resistance risks when using reclaimed municipal wastewater for agriculture -- Antibiotic resistance in soil -- Religious Mass Gathering (Hajj) and Antimicrobial Resistance: From Challenges to Opportunities -- Human movement and transmission of anti-microbial resistant bacteria. |
| Record Nr. | UNINA-9910416142403321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents [[electronic resource] /] / edited by Michael W. Jann, Scott R. Penzak, Lawrence J. Cohen
| Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents [[electronic resource] /] / edited by Michael W. Jann, Scott R. Penzak, Lawrence J. Cohen |
| Edizione | [1st ed. 2016.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Adis, , 2016 |
| Descrizione fisica | 1 online resource (597 p.) |
| Disciplina | 610 |
| Soggetto topico |
Psychopharmacology
Pharmacy Drug Safety and Pharmacovigilance |
| ISBN | 3-319-27883-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Section 1. General Pharmacokinetic and Pharmacodynamic Principles of Psychopharmacological Agents -- 1. Pharmacokinetic Properties -- 2. Pharmacodynamic Properties -- 3. PET Scan and Other Biomarkers -- 4. Population Pharmacokinetics -- 5. Drug Transporters (esp. Blood Brain Barrier) -- 6. Pharmacogenomics -- Section 2. Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Drug Classes -- 7. Antipsychotics – oral typical agents, oral atypical agents, and long-acting injectable (LAI) antipsychotics -- 8. Mood Stabilizers -- 9. Antidepressants – tricyclics, selective serotonergic reuptake inhibitors, serotonergic noradrenergic reuptake inhibitors, monoamine oxidase inhibitors, and other antidepressants -- 10. Benzodiazepines and Other Sedative Hypnotics/Anxiolytics -- 11. Opioid Analgesics -- 12. Stimulants and Other Non-Stimulants for ADHD -- 13. Cholinesterase Inhibitors and Other Antidementa Agents -- 14. Anti-Addiction Agents -- 15. Anesthetics -- Section 3. Clinically Significant Drug Interactions With Psychopharmacological Agents -- 16. Antipsychotics -- 17. Mood Stabilizers -- 18. Antidepressants -- 19. Benzodiazepines and Other Sedative Hypnotics/Anxiolytics -- 20. Opioid Analgesics -- 21. Stimulants and Other Non-Stimulants for ADHD -- 22. Cholinesterase Inhibitors and Other Antidementa Agents -- 23. Anti-Addiction Agents -- 24. Anesthetics. |
| Record Nr. | UNINA-9910254508503321 |
| Cham : , : Springer International Publishing : , : Imprint : Adis, , 2016 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Atlas of Osteoarthritis [[electronic resource] /] / by Nigel Arden, Francisco Blanco, C. Cooper, Ali Guermazi, Daichi Hayashi, David Hunter, M. Kassim Javaid, Francois Rannou, Frank Roemer, Jean-Yves Reginster
| Atlas of Osteoarthritis [[electronic resource] /] / by Nigel Arden, Francisco Blanco, C. Cooper, Ali Guermazi, Daichi Hayashi, David Hunter, M. Kassim Javaid, Francois Rannou, Frank Roemer, Jean-Yves Reginster |
| Autore | Arden Nigel |
| Edizione | [1st ed. 2014.] |
| Pubbl/distr/stampa | Tarporley : , : Springer Healthcare Ltd. : , : Imprint : Springer Healthcare, , 2014 |
| Descrizione fisica | 1 online resource (99 p.) |
| Disciplina |
353998
610 616723 |
| Soggetto topico |
Rheumatology
Pharmacy Family medicine Drug Safety and Pharmacovigilance General Practice / Family Medicine |
| ISBN | 1-910315-16-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Introduction: historical and current perspectives on osteoarthritis -- Epidemiology of osteoarthritis -- Pathophysiology of osteoarthritis -- Clinical features and diagnosis of osteoarthritis -- Assessing joint damage in osteoarthritis -- Treatment of osteoarthritis. |
| Record Nr. | UNINA-9910300061003321 |
Arden Nigel
|
||
| Tarporley : , : Springer Healthcare Ltd. : , : Imprint : Springer Healthcare, , 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Benefit-Risk Assessment of Medicines [[electronic resource] ] : The Development and Application of a Universal Framework for Decision-Making and Effective Communication / / by James Leong, Sam Salek, Stuart Walker
| Benefit-Risk Assessment of Medicines [[electronic resource] ] : The Development and Application of a Universal Framework for Decision-Making and Effective Communication / / by James Leong, Sam Salek, Stuart Walker |
| Autore | Leong James |
| Edizione | [1st ed. 2015.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Adis, , 2015 |
| Descrizione fisica | 1 online resource (326 p.) |
| Disciplina |
306
353998 610 |
| Soggetto topico |
Pharmacy
Medical research Drug Safety and Pharmacovigilance Quality of Life Research |
| ISBN | 3-319-15805-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Prologue -- Preface -- Overview -- Approaches to utilising decision-making framework -- Benefit-risk assessment of medicines by pharmaceutical companies and regulatory authorities -- Development of a universal benefit-risk framework and template -- Implementation of the benefit-risk assessment template by mature agencies -- Implementation of the benefit- risk summary template by a maturing agency: A case study -- Communicating benefit-risk decisions by US FDA, EMA, TGA and Health Canada -- Conclusions and future directions -- References. |
| Record Nr. | UNINA-9910300234003321 |
|
Leong James
|
||
| Cham : , : Springer International Publishing : , : Imprint : Adis, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cancer Policy: Pharmaceutical Safety [[electronic resource] /] / edited by June M. McKoy, Dennis P. West
| Cancer Policy: Pharmaceutical Safety [[electronic resource] /] / edited by June M. McKoy, Dennis P. West |
| Edizione | [1st ed. 2019.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019 |
| Descrizione fisica | 1 online resource (129 pages) |
| Disciplina | 615.10289 |
| Collana | Cancer Treatment and Research |
| Soggetto topico |
Oncology
Pharmacy Oncology Drug Safety and Pharmacovigilance |
| ISBN | 3-319-43896-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Pharmacovigilance programs: Do they improve Cancer Drug Safety? -- Impact of Cost on the Safety of Cancer pharmaceuticals -- Assessing pharmaceutical safety in Geriatric Oncology -- Cancer co-Morbidity: Implications for Drug Safety -- Statistical aids to signal generation: Are they effective in Identifying Adverse Cancer Drug Reactions? -- Pharmacovigilance of alternative medications in the Cancer Setting -- Key elements in Adverse Drug Interaction Safety Signals: evaluation of individual case reports in oncology -- Biosimilars: Are they really safe? -- Natural Language processing: improving the identification and communication of Cancer Drug Safety -- The Drug Shortage Crisis in the United States: Impact on cancer pharmaceutical safety -- Anatomy of Risk Evaluation and Mitigation Strategies (REMS) -- Cancer Drug Toxicity: Moving from patient to Survivor. |
| Record Nr. | UNINA-9910337507003321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Carbon Nanotubes for Targeted Drug Delivery [[electronic resource] /] / by Md Saquib Hasnain, Amit Kumar Nayak
| Carbon Nanotubes for Targeted Drug Delivery [[electronic resource] /] / by Md Saquib Hasnain, Amit Kumar Nayak |
| Autore | Hasnain Md Saquib |
| Edizione | [1st ed. 2019.] |
| Pubbl/distr/stampa | Singapore : , : Springer Singapore : , : Imprint : Springer, , 2019 |
| Descrizione fisica | 1 online resource (XIV, 106 p. 21 illus., 16 illus. in color.) |
| Disciplina | 620.115 |
| Collana | SpringerBriefs in Applied Sciences and Technology |
| Soggetto topico |
Nanotechnology
Pharmaceutical technology Pharmacy Pharmaceutical Sciences/Technology Nanotechnology and Microengineering Drug Safety and Pharmacovigilance |
| ISBN | 981-15-0910-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Introduction -- Chemical and physical properties of Carbon Nanotubes -- Classification of Carbon Nanotubes -- Preparation of Carbon Nanotubes -- Functionalization of Carbon Nanotubes -- Carbon Nanotubes Characterization -- Applications of Carbon Nanotubes -- Carbon Nanotubes absorption and transportation -- Carbon Nanotubes Toxicity Consideration -- Carbon Nanotubes Regulatory considerations -- Carbon Nanotubes Clinical trials and market status -- Conclusion. |
| Record Nr. | UNINA-9910357827303321 |
|
Hasnain Md Saquib
|
||
| Singapore : , : Springer Singapore : , : Imprint : Springer, , 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cardiovascular Safety in Drug Development and Therapeutic Use [[electronic resource] ] : New Methodologies and Evolving Regulatory Landscapes / / by J. Rick Turner, Dilip R. Karnad, Snehal Kothari
| Cardiovascular Safety in Drug Development and Therapeutic Use [[electronic resource] ] : New Methodologies and Evolving Regulatory Landscapes / / by J. Rick Turner, Dilip R. Karnad, Snehal Kothari |
| Autore | Turner J. Rick |
| Edizione | [1st ed. 2017.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Adis, , 2017 |
| Descrizione fisica | 1 online resource (XXVI, 333 p. 2 illus. in color.) |
| Disciplina | 353.998 |
| Soggetto topico |
Pharmacy
Cardiology Drug Safety and Pharmacovigilance |
| ISBN | 3-319-40347-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | The Central Importance of Cardiovascular Safety in Contemporary New Drug Development -- The Biological Basis of Drug Responses -- Cardiovascular Structure, Function, Pathophysiology, & Disease -- The Current Regulatory Landscape -- The "Comprehensive In Vitro Proarrhythmia Assay" Initiative -- The "Early ECG Assessment" Initiative -- The "Submission of Extended Digital ECG Data" Initiative -- Meta-analysis and Meta-methodology -- Current Regulatory Landscapes and their Potential Evolution -- Off-target Blood Pressure Responses to Non-cardiovascular Drugs -- Oncology Drug Development and Therapeutics: Cardiotoxicity Considerations -- Postmarketing Surveillance -- Regulatory Perspectives on General Drug Safety -- Future Directions in Cardiovascular Safety -- References. |
| Record Nr. | UNINA-9910254496803321 |
|
Turner J. Rick
|
||
| Cham : , : Springer International Publishing : , : Imprint : Adis, , 2017 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The Challenge of CMC Regulatory Compliance for Biopharmaceuticals [[electronic resource] /] / by John Geigert
| The Challenge of CMC Regulatory Compliance for Biopharmaceuticals [[electronic resource] /] / by John Geigert |
| Autore | Geigert John |
| Edizione | [3rd ed. 2019.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019 |
| Descrizione fisica | 1 online resource (338 pages) |
| Disciplina | 615.7 |
| Soggetto topico |
Pharmacology
Pharmacy Pharmacology/Toxicology Drug Safety and Pharmacovigilance |
| ISBN | 3-030-13754-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Complexity of Biologics CMC Regulation -- Biopharmaceutics are Not Chemical Drugs -- An Effective CMC Strategy is Possible -- Challenge of Adventitious Agent Control -- Biopharmaceutical Source Materials -- Manufacturing of Biopharmaceutical APIs -- Manufacturing of the Drug Product -- Complex Process-Related Impurity Profiles -- Product Characterization is a Journey -- Priceless Potency (Therapeutic Activity) -- Quality Attributes of a Biopharmaceutical -- Designing the Stability Program -- The Art of Setting Specifications -- Demonstrating Product Comparability After Process Changes -- Invaluable CMC-Focused Meetings with Regulatory Authorities. |
| Record Nr. | UNINA-9910337940703321 |
|
Geigert John
|
||
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Chemotherapy in Neonates and Infants [[electronic resource] ] : Pharmacological Oncology for Children Under 1 Year Old / / by Carolina Witchmichen Penteado Schmidt
| Chemotherapy in Neonates and Infants [[electronic resource] ] : Pharmacological Oncology for Children Under 1 Year Old / / by Carolina Witchmichen Penteado Schmidt |
| Autore | Penteado Schmidt Carolina Witchmichen |
| Edizione | [1st ed. 2018.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2018 |
| Descrizione fisica | 1 online resource (xix, 198 pages) : illustrations |
| Disciplina | 362.19892994 |
| Soggetto topico |
Pediatrics
Oncology Hematology Pharmacy Cancer research Oncology Drug Safety and Pharmacovigilance Cancer Research |
| ISBN | 3-319-70591-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 1. Introduction -- 2. Protocols used in chemotherapy treatment of neonates and infants -- 3. Pharmacokinetics of Chemotherapy Drugs in Neonates and Infants -- 4. Pharmacodinamics of Chemotherapy Drugs in Neonates and Infants -- 5. List of Chemotherapy Drugs in Neonates and Infants -- 6. List of Adjuvant Drugs in Chemotherapy of Neonates and Infants -- 7. Drug Interactions in Neonates and Infants -- 8. Toxicity -- 9. Tumor Lysis in Neonates and Infants -- 10. Chemotherapy in Neonates and Infants with Congenital Diseases -- 11. Bone Marrow Transplantation in Neonates and Infants -- 12. Body Surface of Neonates -- 13. Body Surface of Infants -- 14. Glossary. |
| Record Nr. | UNINA-9910300266703321 |
|
Penteado Schmidt Carolina Witchmichen
|
||
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2018 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Soggetto topico
-
Drug Safety and Pharmacovigilance
(49)
- Pharmacy (44)
- Pharmacology (16)
- Pharmacology/Toxicology (9)
- Pharmacovigilance (9)